600833 第一医药
2025/06 - 中期2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)1.25215.2609.14216.6686.532
总资产报酬率 ROA (%)0.7038.4864.5768.5113.619
投入资产回报率 ROIC (%)0.94311.1356.09811.6145.222

边际利润分析
销售毛利率 (%)16.53916.63019.10120.52517.737
营业利润率 (%)1.29310.8645.4387.1782.513
息税前利润/营业总收入 (%)1.32110.5616.1537.1993.310
净利润/营业总收入 (%)1.4378.5434.9075.4053.534

收益指标分析
经营活动净收益/利润总额(%)20.8723.03823.417118.75746.756
价值变动净收益/利润总额(%)47.8476.14320.3082.3132.976
营业外收支净额/利润总额(%)27.3533.79115.791-0.05946.138

偿债能力分析
流动比率 (X)1.5871.7391.6511.5081.492
速动比率 (X)1.0031.2201.1601.1471.009
资产负债率 (%)44.50642.20445.87452.98541.705
带息债务/全部投入资本 (%)11.18614.19314.96428.2555.102
股东权益/带息债务 (%)690.625518.897482.544218.5471,623.254
股东权益/负债合计 (%)123.674135.894117.16788.083138.520
利息保障倍数 (X)-2.872-14.425-20.157277.658-2.442

营运能力分析
应收账款周转天数 (天)31.36540.54447.48525.18234.033
存货周转天数 (天)82.35575.37081.56346.83867.300